Evaluation of the Suitability of Using Anticholesterol Drugs in Cholesterol Patients at Sekip Public Health Centre Palembang
DOI:
https://doi.org/10.30872/j.trop.pharm.chem.v7i2.156Keywords:
Cholesterol, Cholesterol Drugs, Dyslipidemia, Public Health Centre, Drug RationalityAbstract
Dyslipidemia is a condition that increases plasma cholesterol, LDL, and triglyceride levels, decreases HDL levels, or causes a combination of abnormalities. In amounts sufficient for what the body needs, cholesterol works to produce hormones, vitamin D, and other components. Cholesterol is produced by the liver and can also be found in animal products. This study aims to determine the profile of treatment and the suitability of the use of anticholesterol drugs in patients with high cholesterol at Sekip Public Health Centre Palembang. This research is non-experimental, using quantitative methods and 40 samples. The demographic results of the total cholesterol levels of patients who experienced a decrease were 100 patients (100%). Demographics of patients by gender: mostly female, as many as 30 patients (75%). Demographics of patients by age: mostly in the age category 56–65 years, as many as 16 patients (40%). Demographics of patients based on comorbidities: the most common was diabetes mellitus, with as many as 12 patients (30%) The highest use of anticholesterol drugs is in the statin group, namely simvastatin (100%). The suitability of the selection of anticholesterol drugs was 100% for 100 patients. The suitability of the selection of the anticholesterol dose in 100 patients (100%)
References
Triharyanto, B. (2020). Cara Mudah Mengontrol Kolesterol. Kreatifa Prima, Jakarta.
Saragih, B. (2011). Kolesterol dan Usaha-usaha Penurunannya. Bimotry, Yogyakarta.
Yusira, P., Wahyuni, Y., dan Hartati, L.S. (2016). Hubungan Asupan Serat, Lemak, Aktivitas Fisik dan Kadar LDL pada Pasien Penyakit Jantung Koroner di RSUD Dr. M. Yunus Bengkulu Tahun 2016. Nutrire Diaita. 9.
Hastuti, P., Martantiningtyas, D.C., Beandrade, M.U. (2021). Lipoprotein, Apolipoprotein, dan Sindrom Metabolik. Gadjah Mada University Press, Yogyakarta.
Suhadi, R., et al. (2017). Seluk-Beluk Hiperlipidemia Peningkatan Partisipasi dan Kompetensi Farmasis dalam Pencegahan Penyakit Kardiovaskuler. Sanata Dharma University Press, Yogyakarta.
WHO. (2013). A Global Brief on Hypertension Silent Killer, Global Public Health Crisis. Geneva, Switzerland.
WHO. (2011). Global status report on noncommunicable diseases 2010. Geneva, Switzerland.
WHO. (2002). Years of healthy life can be increased 5-10 years, WHO says. Geneva: World Health Organization. (https://www.who.int/news/item/ 30-10-2002-years-of-healthy-life-can-be-increased-5-10-years-who-says accessed on 14 December 2021.
RISKESDAS. (2019). Laporan Nasional RISKESDAS 2018. Badan Penelitian dan Pengembangan Kesehatan, Departemen Kesehatan Republik Indonesia, Jakarta
Kemenkes RI. (2017). Profil Penyakit Tidak Menular Tahun 2016. Kementerian Kesehatan RI, Jakarta
Alshamiri, M., et al. (2018). Expert Opinion on The Applicability of Dyslipidemia Guidelines In Asia and The Middle East. International Journal of General Medicine. 11, 313–322.
DinKes Kota Palembang. (2018). Profil Kesehatan Tahun 2018. Dinas Kesehatan Kota Palembang, Palembang.
DinKes Kota Palembang. (2019). Profil Kesehatan Tahun 2019. Dinas Kesehatan Kota Palembang, Palembang.
Perkumpulan Endokrinologi Indonesia (PERKENI). (2021). Pedoman Pengelolaan Dislipidemia di Indonesia 2021. PB Perkeni, Jakarta.
Nur, R.W., Heru N., dan Aniq, B. (2021). Gambaran Penggunaan Obat Hiperlipidemia di Puskesmas Talang Kabupaten Tegal. Jawa Tengah: Jurnal Ilmiah Farmasi. X.
Suwarsi, S. (2017). Penurunan Kadar Kolesterol Darah pada Kelompok Lansia yang diberikan Terapi Aktivitas Fisik di Desa Wedomartani Sleman. Jurnal Keperawatan Respati Yogyakarta, 4(3), 252–255.
Pramudyawardani, A. (2019). Hubungan Tekanan Darah, Lingkar Pinggang, Asupan Vitamin C Dengan Kadar Kolesterol Pasien Hiperkolesterolemia Rawat Jalan Ddi RSUD Dr. Moewardi Surakarta. Skripsi. PKU Muhammadiyah Surakarta, Surakarta.
Prastiwi, D.A., Swastini, I.G.A.A.P., dan Sudarmanto, I.G. (2021). Gambaran Kadar Kolesterol Total pada Lansia di Puskesmas I Denpasar Selatan. Meditory. 9.
Rahmawati, Y., Ramadanty, D.D., Rahmawati, F., dan Perwitasari, E. (2022). Hiperkolesterolemia pada Pasien Lanjut Usia: Studi Kasus Puskesmas Seyegan. Jurnal Kesehatan Tambusai. 3.
Magfirah, U., Setyowati, dan Sumirah. (2014). Faktor faktor yang Berhubungan dengan Kadar Kolesterol Darah Pasien Penyakit Jantung Rawat Inap di RSUD Banyumas. Jurnal Nutrisia.1(6):10-16.
Parhofer, K.G. (2015). Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia. Diabetes & Metabolism Journal. 39 (5): 353-362.
Singh, O., Gupta, M., and Khajuria, V. (2015). Lipid Profile and its Relationship with Blood Glucose Levels in Metabolic Syndrome. National Journal of Physiology, Pharmacy & Pharmacology. 5(2): 134-137.
Permatasari, R., Suriani, E., dan Kurniawan. (2022). Hubungan Kadar Kolesterol Total dengan Tekanan Darah pada Pasien Hipertensi pada Usia ? 40 Tahun. Jurnal Labora Medika 6.
Aulia, S.S., Sopyan. I., dan Muchtaridi. (2016). Penetapan Kadar Simvastatin Menggunakan Kromatografi Cair Kinerja Tinggi (KCKT): Review. Farmaka. 14.
Talreja, O., Kerndt, C.C., Cassagnol, M. (2020). Simvastatin. NCBI Bookshelf.
Kemenkes RI. (2011). Modul Penggunaan Obat Rasional. Kementerian Kesehatan RI, Jakarta.
Depkes RI. (2007). Pedoman Penggunaan Obat Bebas dan Obat Bebas Terbatas. Departemen Kesehatan RI, Jakarta.
Tjay, Hoan, T., dan Rahardja, K. (2007). Obat-Obat Penting Khasiat, Penggunaan dan Efek-Efek Sampingnya, Edisi Keenam. PT. Elex Media Komputindo, Jakarta
Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI). (2017). Pedoman Tatalaksana Dislipidemia. Centra Communications, Indonesia.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dhiny Zsa Zsa Aulia, Tahoma Siregar, Ritha Widyapratiwi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
